The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Surprised he is not asking why it is going up!
Phil, there are not usually any fees for this type of issue.
It will almost certainly be a 7.00am RNS for the Interim results
No Presentation or Investor conference has been specified.
Although these are just Interim results you would usually expect some information on current trading and forward guidance, so we should have some new information, updates, future prospects etc.
You certainly need educating.
Do you know of any other tests ODX make apart from the Mologic one?
Thanks for coming back Cuddles, you make some fair and valid points, all of which I had missed, not paying enough attention, probably because not holding
at the moment.
Will not be able to listen tomorrow, but no doubt you will be posting the important bits.
Thanks again and good luck.
Cuddles and others.
You seem very excited by this company and seem to have much more insight into it than I can find out.
Why on Monday will we know more? Is there an Investors Conference or some announcement that I am unaware of?
FAB isa Contract Research Organisation i.e. they provide Research services outsourced on a Contract basis. (They get paid for the work they are contracted to do).
Can you point me to any agreement whereby they receive extra fees or Royalty payments if their work leads to any drug/vaccine becoming commercially successful?
They are not a Pharma or Diagnostic company as some seem to think.
I did post having got out towards the top of the spike that I would consider a re-entry at around 120p, which we have now fallen below..
However they are still loss making, with little in the Interim report to excite me and all the previous talk on here of 5 bagger, 10 bagger etc. seems pie in the sky to me.
I need some concrete facts to get me back in, even at this level.
No, Market Markers only report the trade price, not wether it was a buy or a sell.
If you had researched you would see neither of those two companies have any open short positions
Look at the size of those buys - not much to get excited about.
Think that's BioVendor, a Czech company.
You keep hearing voices all the while Spurs.
Probably best if you see a Psychiatrist.
If you took the time to read the London Stock Exchange rules you would understand the Late reported trades.
It has nothing to do with the Market Makers, any deceipt or the fact we are on AIM.
The same rules apply across the whole market
Sorry, AB should of course be FAB!
There is no connection between AB and Regeneron that I can find.
No further comment from Matarakz.
As for JRjnr no further comment from him either, he is best ignored if you look at his posting history, totally clueless.
As with many AIM shares a lack of news means they just drift down as investors lose interest, it will take some news to get this moving again.
FAB not renowned for their newsflow, so we may have to wait until end of Jan. for their trading update.
We have no idea of the volume of sales or whom they are too so impossible to put any sort of valuation on this.
Am currently out of this but watching , and if it retraced to around 120p before any news would consider re-entering.
Could you possibly enlighten us with your vast experience as to how the share price should behave?
I have been doing this 40 years and cannot find the answer.
Almost certainly I would have thought, we will know if it's true in the morning
We may have mildly crossed swords in the past but I send you my best wishes for a full and speedy recovery.
Admire your optimism JR, but fear it is sadly misplaced.
FAB do not have a Covid test, people has mis-interpreted the RNS.
Anyway its falling back now
Because there were more shares sold than bought basically, remember it is a market, supply and demand drives the price.